Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: A 10-year cohort study

Digestive and Liver Disease

Volumn 44, Issue 5, 2012, Pages 369-374

  Kohn, Anna ^a   Fano, Valeria ^b   Monterubbianesi, Rita ^a   Davoli, Marina ^b   Marrollo, Marzia ^a   Stasi, Elisa ^a   Perucci, Carlo ^b   Prantera, Cosimo ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b Italian National Health Service   (Italy)

Author keywords

Epidemiology; Inflammatory bowel disease; Surgery

Indexed keywords

ADULT; ARTICLE; COLON RESECTION; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; SECOND LOOK SURGERY; SURVIVAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84859209339     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.11.009     Document Type: Article

References (34)

1. Trallori G., Palli D., Saieva C., et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-1992). Scand J Gastroenterol 1996, 31:892-899.
2. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
3. Vind I., Riis L., Jess T., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006, 101:1274-1282.
4. Bjornsson S., Johannsson J.H. Inflammatory bowel disease in Iceland 1990-1994: a prospective nationwide epidemiological study. Eur J Gastroenterol Hepatol 2000, 12:31-38.
5. Jacobsen B.A., Fallingborg J., Rasmussen Nielsen K.R., et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 2006, 18:601-606.
6. Rice-Oxley J.M., Truelove S. Ulcerative colitis: course and prognosis. Ibid 1950, 1:663-666.
7. Edwards F.C., Truelove S.C. The course and prognosis of ulcerative colitis. Gut 1963, 4:299-308.
8. Softley A., Clamp S.E., Watkinson G., et al. The natural history of inflammatory bowel disease: has there been a change in the last 20 years?. Scand J Gastroenterol Suppl 1988, 144:20-23.
9. Cohen R.D., Yu A.P., Wu E.Q., et al. Systematic review: the costs of ulcerative colitis in the Western countries. Aliment Pharmacol Ther 2010, 31:693-707.
10. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
11. Jarnerot G., Hertervig E., Friis-Liby I., et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005, 128:1805-1811.
12. Kohn A., Daperno M., Armuzzi A., et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 2007, 26:747-756.
13. Tsai H.H., Punekar Y.S., Morris J., et al. A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis. Aliment Pharmacol Ther 2008, 28:1230-1239.
14. Loftus E.V., Silverstein M.D., Sandbom W.J., et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000, 46:336-343.
15. Farmer R.G., Easley K.A., Rankin G.B. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993, 38:1137-1146.
16. Hendriksen C., Kreiner S., Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985, 26:158-163.
17. Jess T., Riis L., Vind I., et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007, 13:481-489.
18. Winther K.V., Jess T., Langholz E., et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003, 125:1576-1582.
19. Henriksen M., Jahnsen J., Lygren I., et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow up study (the IBSEN study). Inflamm Bowel Dis 2006, 12:543-550.
20. Souza M.H., Troncon L.E., Rodrigues, et al. Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil. Arq Gastroenterol 2002, 39:98-105.
21. Tezel A., Dokmeci G., Eskiocak M., et al. Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res 2003, 31:141-148.
22. Masala G., Bagnoli S., Ceroti M., et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut 2004, 53:1309-1313.
23. Meucci G., Vecchi M., Astegiano M., et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 2000, 95:469-473.
24. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal Congress of Gastroenterology. Can J Gastroenterol 2005, 19:5-36.
25. Centers for Disease Control and Prevention, National Center for Health Statistics. *International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM). Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm.
26. Francesco Taroni, DRG/ROD e nuovo sistema di finanziamento degli ospedali, Il Pensiero Scientifico Editore; 1996, http://www.drg.it/.
27. Langholz E., Munkholm P., Davidsen M., et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992, 103:1444-1451.
28. Nguyen G.C., Tuskey A., Dassopoulos T., et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis 2007, 13:1529-1535.
29. Bernstein C.N., Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 2006, 101:110-118.
30. Leijonmarck C.E., Persson P.G., Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31:329-333.
31. Langholz E., Munkholm P., Davidsen M., Blinder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994, 107:3-11.
32. Hoie O., Wolters F.L., Riis L., et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007, 132:507-515.
33. Roberts S.E., Williams J.G., Yeates D., et al. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. Br Med J 2007, 335:1033.
34. Moum B., Ekbom A., Vatn M.H., Elgjo K. change in extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999, 94:1564-1569.